These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33821046)

  • 1. The FDA and the COVID-19: A political economy perspective.
    March RJ
    South Econ J; 2021 Apr; 87(4):1210-1228. PubMed ID: 33821046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.
    Bhimraj A; Morgan RL; Shumaker AH; Lavergne V; Baden L; Cheng VC; Edwards KM; Gandhi RT; Gallagher JC; Muller WJ; O'Horo JC; Shoham S; Wollins DS; Falck-Ytter Y
    Clin Infect Dis; 2022 May; 74(9):1686-1690. PubMed ID: 34668010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence base for emergency use authorizations for COVID-19 treatments: A rapid review.
    Knowlson C; Byrne A; Wilkinson J; Whitmore C; Torgerson D
    Health Sci Rep; 2023 Jan; 6(1):e1051. PubMed ID: 36644312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM
    Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shattering the Mirage: The FDA's Early COVID-19 Pandemic Response Demonstrates a Need for Reform to Restore Agency Credibility.
    Fuleihan C
    Am J Law Med; 2022 Dec; 48(4):307-342. PubMed ID: 37039751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Drugs of Uncertain Value, Lifecycle Regulation at the US Food and Drug Administration, and Institutional Incumbency.
    Herder M
    Milbank Q; 2019 Sep; 97(3):820-857. PubMed ID: 31407412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trust and Regulation: Assuring Scientific Independence in the FDA's Emergency Use Authorization Process.
    Patel NG; Kesselheim AS; Darrow JJ
    J Health Polit Policy Law; 2023 Oct; 48(5):799-820. PubMed ID: 36995365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health.
    Zuckerman DM
    Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The political economy of drug and alcohol regulation during the COVID-19 pandemic.
    Redford A; Dills AK
    South Econ J; 2021 Apr; 87(4):1175-1209. PubMed ID: 33821052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of emergency use authorizations for medical products during outbreak situations: a COVID-19 case study.
    Badnjević A; Pokvić LG; Džemić Z; Bečić F
    Biomed Eng Online; 2020 Oct; 19(1):75. PubMed ID: 33008462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to Help.
    Waxman H; Corr B; Martin K; Duong S
    Issue Brief (Commonw Fund); 2018 Apr; 2018():1-10. PubMed ID: 29992802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future.
    Largent EA
    J Law Biosci; 2016 Dec; 3(3):489-537. PubMed ID: 28852537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zohydro approval by food and drug administration: controversial or frightening?
    Manchikanti L; Atluri S; Candido KD; Boswell MV; Simopoulos TT; Grider JS; Falco FJ; Hirsch JA
    Pain Physician; 2014; 17(4):E437-50. PubMed ID: 25054396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19.
    Zarenezhad E; Behrouz S; Farjam M; Rad MNS
    Russ J Bioorg Chem; 2021; 47(3):609-621. PubMed ID: 34149273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life cycle of medical product rules issued by the US Food and Drug Administration.
    Hwang TJ; Avorn J; Kesselheim AS
    J Health Polit Policy Law; 2014 Aug; 39(4):751-80. PubMed ID: 24842974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The political economy of the COVID-19 pandemic.
    Boettke P; Powell B
    South Econ J; 2021 Apr; 87(4):1090-1106. PubMed ID: 33821055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.